Cell metabolism

Gamma-Butyrobetaine is a gut microbe-produced compound that may promote artery disease by converting L-carnitine into TMAO

Updated

Abstract

Following L-carnitine ingestion, γ-butyrobetaine is produced at a rate ∼1,000-fold higher than trimethylamine.

  • γ-Butyrobetaine is identified as the major gut microbial metabolite formed from dietary L-carnitine in mice.
  • γ-Butyrobetaine is converted into trimethylamine and trimethylamine-N-oxide in a manner dependent on gut microbes.
  • The production of γ-butyrobetaine is associated with the acceleration of atherosclerosis.
  • Distinct gut microbial taxa are linked to the metabolism of L-carnitine and γ-butyrobetaine.
  • Chronic dietary exposure to L-carnitine or γ-butyrobetaine leads to the development of functionally distinct microbial communities.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Competing Financial Interest Disclosure . Drs. Wang and Levison are named as co-inventors on pending patents held by the Cleveland Clinic relating to cardiovascular diagnostics. Dr. Tang received research grant support from Abbott Laboratories, and served as consultants for Medtronic Inc and St. Jude Medical. Drs. Hazen and Smith are named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. Dr. Smith reports he has been paid as a consultant by Esperion, and has the right to recieve royalty payments for inventions from Cleveland Heart Lab and Esperion. Dr. Hazen reports he has been paid as a consultant or speaker by the following companies: Cleveland Heart Lab, Inc., Esperion, Liposciences Inc., Merck & Co., Inc., Pfizer Inc., and Proctor & Gamble. Dr. Hazen reports he has received research funds from Abbott, Cleveland Heart Lab, Liposciences, Inc., Proctor & Gamble, and Takeda. Dr. Hazen has the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics and therapeutics from Cleveland Heart Lab, Inc., Esperion, Frantz Biomarkers, and Liposciences, Inc.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free